Anixa biosciences inc (ANIX)
Income statement / Yearly
Oct'19Oct'18Oct'17Oct'16Oct'15Oct'14Oct'13Oct'12Oct'11Oct'10
Revenue

250

1,112

362

300

-

-

-

-

-

-

Revenue from licensing activities

-

-

-

-

255

2,480

388

0

-

-

Revenue from sales of encryption products, net

-

-

-

-

-

-

-

-

130

130

Amortization of display technology development and license fees received from AU Optronics Corporation in fiscal year 2011

-

-

-

-

-

1,187

0

940

872

600

Settlement with AU Optronics Corporation

-

-

-

-

9,000

-

-

-

-

-

Total revenue

-

-

-

-

9,255

3,667

388

940

1,003

730

Operating costs and expenses:
Inventor royalties and contingent legal fees

-

-

-

-

-

-

-

0

-

-

Litigation and licensing expenses

-

-

-

106

3,500

575

108

0

-

-

Inventor royalties, contingent legal fees, litigation and licensing expenses

166

768

104

111

147

1,412

207

-

-

-

Amortization of patents

418

325

325

325

325

314

0

-

-

-

Cost of encryption products sold

-

-

-

-

-

-

-

-

34

82

Research and development expenses (including non-cash share-based compensation expenses of $397,523 and $1,573,779, respectively)

5,473

6,813

1,597

1,556

711

-

-

2,211

3,124

3,007

General and administrative expenses (including non-cash share-based compensation expenses of $623,811 and $1,176,385, respectively)

5,662

6,911

4,410

2,709

5,514

6,408

7,989

2,863

2,872

2,889

Impairment in carrying amount of patent asset

418

582

-

-

-

-

-

-

-

-

Total operating costs and expenses

12,140

15,401

6,438

4,809

10,199

8,711

8,306

5,074

6,031

5,978

Loss from operations

-11,890

-14,289

-6,075

-4,509

-944

-5,044

-7,917

-4,134

-5,028

-5,248

Impairment in value of Videocon Industries Limited global depository receipts

-

-

-

-

-

-62

-1,184

0

-1,785

-

Impairment in value of investment in VolgaSvet Ltd.

-

-

-

-

-

-

-

127

-

-

Change in value of derivative liability (Note 5)

-

-

-

-

-

-592

475

0

-

-

Gain on extinguishment of patent acquisition obligation (Note 4)

-

-

1,547

0

-

-2,699

-343

0

-

-

Interest expense (Notes 4 and 5)

-

-

500

519

451

1,263

1,109

7

-

-

Dividend income

-

-

-

-

-

47

0

13

-

68

Dividend income

-

-

-

-

-

-

-

-

33

-

Interest income

71

45

19

12

17

8

0

3

2

4

Loss before income taxes

-11,818

-14,243

-5,008

-5,016

-1,379

-9,606

-10,080

-4,252

-6,778

-5,175

Provision for income taxes

-

-

-

0

0

0

0

0

600

0

Net loss

-11,818

-14,243

-5,008

-5,016

-

-

-

-

-

-

Less: Net loss attributable to noncontrolling interest

-171

-247

-

-

-

-

-

-

-

-

Net loss attributable to common shareholders before deemed dividend

-

-

-5,008

-5,016

-1,379

-9,606

-10,080

-4,252

-7,378

-5,175

Deemed dividend to preferred stockholder (Note 5)

-

-

2,008

0

-

-

-

-

-

-

Net loss attributable to common shareholders

-11,647

-13,996

-7,017

-

-

-

-

-

-

-

Reversal of unrealized loss as of October 31, 2012, on investment in Videocon Industries Limited global depository receipts

-

-

-

-

-

-

653

-

-

-

Total comprehensive (loss) income

-

-

-

-

-

-

-9,426

-

-

-

Basic and diluted (in Dollars per share)

-0.59

-0.79

-0.58

-0.57

-16.00

-1.10

-0.05

-0.02

-0.04

-0.03

Weighted average common shares outstanding:
Basic and diluted (in Shares)

19,789

17,624

12,197

8,739

8,760

8,710

196,645

181,677

166,859

-

Basic and diluted

-

-

-

-

-

-

-

-

-

148,471